title: Anti-adalimumab antibodies in paediatric rheumatology patients: a pilot experience.
authors.affiliation: Pediatric Rheumatology Unit, Immunology Unit and Pediatric Ophthalmology Unit, University Hospital La Paz, Madrid, Spain. saramaria.murias@salud.madrid.org sarapepo@yahoo.es.
authors.forename: Sara
authors.initials: S
authors.lastname: Murias
authors.affiliation: Pediatric Rheumatology Unit, Immunology Unit and Pediatric Ophthalmology Unit, University Hospital La Paz, Madrid, Spain.
authors.forename: Rosa
authors.initials: R
authors.lastname: Alcobendas
authors.affiliation: Pediatric Rheumatology Unit, Immunology Unit and Pediatric Ophthalmology Unit, University Hospital La Paz, Madrid, Spain.
authors.forename: Dora
authors.initials: D
authors.lastname: Pascual-Salcedo
authors.affiliation: Pediatric Rheumatology Unit, Immunology Unit and Pediatric Ophthalmology Unit, University Hospital La Paz, Madrid, Spain.
authors.forename: Agustin
authors.initials: A
authors.lastname: Remesal
authors.affiliation: Pediatric Rheumatology Unit, Immunology Unit and Pediatric Ophthalmology Unit, University Hospital La Paz, Madrid, Spain.
authors.forename: Jesus
authors.initials: J
authors.lastname: Peralta
authors.affiliation: Pediatric Rheumatology Unit, Immunology Unit and Pediatric Ophthalmology Unit, University Hospital La Paz, Madrid, Spain.
authors.forename: Rosa
authors.initials: R
authors.lastname: Merino
mesh_terms: D000068879:Adalimumab; D000293:Adolescent; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D002648:Child; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D010865:Pilot Projects; D012189:Retrospective Studies; D012216:Rheumatic Diseases / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D001323:Autoantibodies; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab